Elena Cavadini Selected Research

Elena Cavadini Research Topics

14	Neoplasms (Cancer) 04/2017 - 01/2003
7	Neuroblastoma 02/2012 - 06/2003
5	Ovarian Neoplasms (Ovarian Cancer) 04/2017 - 10/2006
5	Breast Neoplasms (Breast Cancer) 01/2017 - 01/2003
5	Carcinoma (Carcinomatosis) 10/2006 - 02/2003
2	Leukoplakia 03/2009 - 07/2005
1	Mesothelioma 01/2017
1	Hemolysis 02/2012
1	Night Blindness (Nyctalopia) 10/2010
1	Drug-Related Side Effects and Adverse Reactions 10/2006
1	Oral Leukoplakia 07/2005
1	Carcinogenesis 09/2004

16	FenretinideIBA 02/2012 - 01/2003
10	RetinoidsIBA 01/2017 - 06/2003
8	Pharmaceutical PreparationsIBA 04/2017 - 01/2003
6	4-oxofenretinideIBA 01/2017 - 09/2004
3	Proteins (Proteins, Gene)FDA Link 04/2017 - 09/2004
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2012 - 05/2009
3	retinamideIBA 10/2010 - 10/2006
3	Vitamin A (Retinol)FDA LinkGeneric 10/2010 - 01/2003
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2012 - 02/2003
2	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2012 - 05/2009
2	Biomarkers (Surrogate Marker)IBA 10/2010 - 10/2006
1	SodiumIBA 01/2017
1	JNK Mitogen-Activated Protein KinasesIBA 01/2012
1	Biological ProductsIBA 01/2012
1	Estrogens (Estrogen)FDA Link 12/2009
1	Estrogen ReceptorsIBA 12/2009
1	Butylated Hydroxyanisole (BHA)IBA 05/2009
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 05/2009
1	AntioxidantsIBA 05/2009
1	Hormones (Hormone)IBA 01/2009
1	Testosterone (Sustanon)FDA Link 07/2007
1	Cellular Retinol-Binding ProteinsIBA 09/2004
1	EnzymesIBA 09/2004
1	cellular retinoic acid binding protein IIBA 09/2004
1	cellular retinoic acid binding protein IIIBA 09/2004
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 09/2004
1	Retinoic Acid 4-Hydroxylase (CYP26B1)IBA 09/2004
1	Insulin-Like Growth Factor Binding Protein 3IBA 10/2003
1	Insulin-Like PeptidesIBA 10/2003
1	Insulin-Like Growth Factor Binding ProteinsIBA 10/2003
1	Insulin-Like Growth Factor I (IGF-1)IBA 10/2003
1	SphingolipidsIBA 02/2003

2	Drug Therapy (Chemotherapy) 02/2012 - 01/2009
2	Therapeutics 10/2010 - 01/2009
1	Intravenous Administration 02/2012
1	Chemoprevention 01/2009
1	Aftercare (After-Treatment) 10/2006